27-Mar-2024
No headlines found.
Business Wire (Tue, 19-Mar 9:00 AM ET)
CEL-SCI Corporation Issues Letter to Shareholders
Business Wire (Wed, 6-Mar 8:45 AM ET)
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results
Business Wire (Thu, 15-Feb 8:00 AM ET)
CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock
Business Wire (Tue, 13-Feb 12:00 PM ET)
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock
Business Wire (Fri, 9-Feb 8:30 AM ET)
Business Wire (Tue, 6-Feb 9:00 AM ET)
Business Wire (Wed, 31-Jan 9:00 AM ET)
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Cel-Sci trades on the AMEX stock market under the symbol CVM.
As of March 27, 2024, CVM stock price climbed to $1.89 with 228,350 million shares trading.
CVM has a beta of 2.59, meaning it tends to be more sensitive to market movements. CVM has a correlation of 0.11 to the broad based SPY ETF.
CVM has a market cap of $102.02 million. This is considered a Micro Cap stock.
In the last 3 years, CVM stock traded as high as $27.86 and as low as $1.04.
The top ETF exchange traded funds that CVM belongs to (by Net Assets): VTI, VXF, IWC, GERM.
CVM has underperformed the market in the last year with a price return of -17.1% while the SPY ETF gained +33.6%. CVM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -36.8% and -8.7%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
CVM support price is $1.76 and resistance is $2.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CVM stock will trade within this expected range on the day.